Table 6.

Summary of X-inactivation studies in polycythemia vera.

Gene(s)
Method
F
L
T
WBC
G
PI
Ret
RBC
NK
G6PD   Protein   0/2   0/2     2/2   2/2    2/2   
PGK, HPRT   DNA      5/6       
PGK   DNA      1/1       
PGK   DNA     0/3   16/17   3/3      
PGK   DNA     0/1    2/3      
PGK, HPRT   DNA     1/8    8/8      
AR   DNA     4/25    21/25      
AR   DNA    2/10   0/3    7/11      
AR   DNA      14/22       
P55, G6PD   RNA     0/3    3/3   3/3   3/3    0/3  
(Adapted from Hinschelwood S et al, 1997) 
Key: For each cell type, numbers represent the number of patients with a skewed X-inactivation ratio over the total number of patients studied. Abbreviations: F, skin or marrow fibroblasts; L, lymphocytes; T, T lymphocytes; WBC, white blood cells; G, granulocytes; PI, platelets; Ret, reticulocytes; RBC, red blood cells; NK, natural killer cells; G6PD, glucose-6-phosphate dehydrogenase; PGK, phosphoglycerate kinase; HPRT, hypoxanthine phosphoryl ribosyl transferase; AR, androgen receptor  
Gene(s)
Method
F
L
T
WBC
G
PI
Ret
RBC
NK
G6PD   Protein   0/2   0/2     2/2   2/2    2/2   
PGK, HPRT   DNA      5/6       
PGK   DNA      1/1       
PGK   DNA     0/3   16/17   3/3      
PGK   DNA     0/1    2/3      
PGK, HPRT   DNA     1/8    8/8      
AR   DNA     4/25    21/25      
AR   DNA    2/10   0/3    7/11      
AR   DNA      14/22       
P55, G6PD   RNA     0/3    3/3   3/3   3/3    0/3  
(Adapted from Hinschelwood S et al, 1997) 
Key: For each cell type, numbers represent the number of patients with a skewed X-inactivation ratio over the total number of patients studied. Abbreviations: F, skin or marrow fibroblasts; L, lymphocytes; T, T lymphocytes; WBC, white blood cells; G, granulocytes; PI, platelets; Ret, reticulocytes; RBC, red blood cells; NK, natural killer cells; G6PD, glucose-6-phosphate dehydrogenase; PGK, phosphoglycerate kinase; HPRT, hypoxanthine phosphoryl ribosyl transferase; AR, androgen receptor  
Close Modal

or Create an Account

Close Modal
Close Modal